Clinical Trial

Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To assess and localize hypoxic tumor subregions both at baseline and during the second week of radiotherapy. And to hypothesize that an intensified IMRT regimen may ensure higher local response rates compared to the standard IMRT approach.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-11.
Trial Details
NCT Number NCT06880289
Lead Sponsor Regina Elena Cancer Institute
Conditions Squamous Cell Tumors of the Head and Neck
Enrollment 91 participants
Start Date 2020-09-16
Primary Completion 2024-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-05